CANALIS Trademark

Trademark Overview


On Friday, September 15, 2017, a trademark application was filed for CANALIS with the United States Patent and Trademark Office. The USPTO has given the CANALIS trademark a serial number of 87609988. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 16, 2019. This trademark is owned by Teewinot Life Sciences Corporation. The CANALIS trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biopharmaceutical drugs for the treatment of pain, inflammation, cancer, seizures, and epilepsy

Custom manufacture of pharmaceuticals and biopharmaceutical drugs; Custom manufacturing of new biological products for others; Custom manufacture of chemical products for others; Custom manufacture of nutraceuticals for others; Custom manufacture of cosmeceuticals for others; Custom manufacture of medical veterinary products for others

Research and development of pharmaceuticals and biopharmaceutical drugs; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering, and organic chemistry; Research and development of new biological products for others; Research and development of new chemical products for others; Nutraceutical research and development for others; Cosmeceutical research and development for others; Veterinary medical research and development for others; Research and development in the field of bioinformatics and proteomics
canalis

General Information


Serial Number87609988
Word MarkCANALIS
Filing DateFriday, September 15, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 16, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements


Goods and ServicesPharmaceutical and biopharmaceutical drugs for the treatment of pain, inflammation, cancer, seizures, and epilepsy
Goods and ServicesCustom manufacture of pharmaceuticals and biopharmaceutical drugs; Custom manufacturing of new biological products for others; Custom manufacture of chemical products for others; Custom manufacture of nutraceuticals for others; Custom manufacture of cosmeceuticals for others; Custom manufacture of medical veterinary products for others
Goods and ServicesResearch and development of pharmaceuticals and biopharmaceutical drugs; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering, and organic chemistry; Research and development of new biological products for others; Research and development of new chemical products for others; Nutraceutical research and development for others; Cosmeceutical research and development for others; Veterinary medical research and development for others; Research and development in the field of bioinformatics and proteomics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 20, 2017
Primary Code005
First Use Anywhere DateFriday, August 10, 2018
First Use In Commerce DateFriday, August 10, 2018

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, September 20, 2017
Primary Code040
First Use Anywhere DateWednesday, October 10, 2018
First Use In Commerce DateWednesday, October 10, 2018

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 20, 2017
Primary Code042
First Use Anywhere DateWednesday, October 10, 2018
First Use In Commerce DateWednesday, October 10, 2018

Trademark Owner History


Party NameTeewinot Life Sciences Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTampa, FL 33626

Party NameTeewinot Life Sciences Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33626

Trademark Events


Event DateEvent Description
Tuesday, July 16, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, July 16, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, December 15, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 15, 2018NON-FINAL ACTION E-MAILED
Saturday, December 15, 2018SU - NON-FINAL ACTION - WRITTEN
Friday, November 16, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, October 22, 2018USE AMENDMENT FILED
Thursday, November 15, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 22, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, September 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 18, 2018EXTENSION 1 GRANTED
Tuesday, September 18, 2018EXTENSION 1 FILED
Tuesday, September 18, 2018TEAS EXTENSION RECEIVED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 5, 2018ASSIGNED TO LIE
Wednesday, December 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, December 20, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 20, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, December 20, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 20, 2017ASSIGNED TO EXAMINER
Wednesday, September 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 19, 2017NEW APPLICATION ENTERED IN TRAM